One week at the China International Import Expo showed a market that is still open to European health and consumer brands, and at the same time much more selective about what it lets in.
That filter is the same one we see when we help brands decide whether, and how, to enter China: the door is open, but only a clearly differentiated offer, with a partner and a willingness to share risk, will walk through it.
Five practical lessons
- 1Being new in Europe is not enough: the product has to be genuinely different in China, or it will struggle.
- 2Entering now means sharing risk on margins, inventory and marketing, not handing the market to a local distributor and stepping back.
- 3This year's deals were about channels: online health platforms, care outside hospitals, and provincial buyers.
- 4Hong Kong, Singapore or Taiwan can run in parallel with China, not as a substitute for it.
- 5China is also a source of innovation. For companies looking for pipeline, the question is how early to partner, not whether to look.
What it takes in consumer health
In the original article, Delphine Yan, Partner at JUMO Partners, describes the filter European consumer brands now meet in China:
“The Chinese market is no more closed than before, but it demands more,”
“A brand needs genuine technological differentiation, a proven track record in its home market, and some initial brand awareness in China. And it has to be willing to share the risks, whether in margins, inventory or marketing investment. This also requires a brand to take greater ownership of its China business. It can no longer treat China as just another B2B ‘client’ and blindly leave everything in the hands of a local distributor. It needs to stay involved, maintain visibility and actively manage its brand in the market to succeed.”
Delphine Yan, Partner at JUMO Partners, in the original JUMO Partners article.